Research Topics
| Mark KiddSummaryAffiliation: Yale University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumorsMark Kidd
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Cancer 103:229-36. 2005..The authors postulated that a similar mechanism occurred during the malignant evolution of small bowel carcinoid tumors...- Global expression analysis of ECL cells in Mastomys natalensis gastric mucosa identifies alterations in the AP-1 pathway induced by gastrin-mediated transformationM Kidd
Gastrointestinal Surgical Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Physiol Genomics 20:131-42. 2004..These results suggest that expression of this receptor and an altered composition of AP-1 with a loss of inhibition play a role in ECL cell transformation... 
Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexedIrvin M Modlin
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520 8062, USA
Ann Surg 244:52-60. 2006..To use differential gene expression of candidate markers to discriminate benign appendiceal carcinoids (APCs) from malignant and mixed cell APCs...- Utility of molecular genetic signatures in the delineation of gastric neoplasiaMark Kidd
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA
Cancer 106:1480-8. 2006..GISTs share similar expression patterns with Type III/IV GCs but have decreased CgA. MTA1 is a marker of tumor invasion... 
Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumorsIrvin M Modlin
Department of Gastroenterological Surgery, Yale University School of Medicine, New Haven, CT 06520 8062, USA
Ann Surg Oncol 16:487-98. 2009..Including NET-related circulating hormones and growth factors in the algorithm increased the sensitivity of detection of SI-NETs from 58 to 82%...- Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1Mark Kidd
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Cancer 109:2420-31. 2007..Whether this phenomenon is common to small intestinal carcinoid tumors was investigated... - Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell linesIgnat Drozdov
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, Connecticut, USA
Cancer 115:4934-45. 2009..Given the expression of 5-HT receptors on NETs, the authors hypothesized that 5-HT autoregulated NET proliferation... - Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learningIgnat Drozdov
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Cancer 115:1638-50. 2009.... - Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell linesMark Kidd
Gastrointestinal Research Group, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Cancer 113:690-700. 2008..Given the coexistence of somatostatin and dopamine regulatory receptors on NET cells, the antiproliferative efficacy as well as the signaling and transcriptional targets of their ligands were evaluated... - The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevantIrvin M Modlin
Gastrointestinal Pathobiology Group, Yale University School of Medicine, 310 Cedar Street, New Haven, CT, USA
Langenbecks Arch Surg 396:1145-56. 2011..All current evidences indicate that their diagnosis and treatment should follow the same common principles... - The diversity and commonalities of gastroenteropancreatic neuroendocrine tumorsSimon Schimmack
Gastrointestinal Pathobiology Research Group, Department of Gastroenterological Surgery, Yale University School of Medicine, New Haven, CT, USA
Langenbecks Arch Surg 396:273-98. 2011..The further acquisition of a detailed biological and molecular appreciation of GEP-NETs is vital to the development of effective management strategy... - Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKTBernhard Svejda
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Cancer 117:4141-54. 2011..Because adenocarcinomas escape mTOR inhibition, we examined whether the escape phenomenon occurred in SINETs and whether usage of somatostatin analogs with mTOR inhibitors surmounted loss of inhibition... - Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapyBjorn I Gustafsson
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520 8062, USA
Int J Oncol 33:1121-31. 2008..We present an overview of the epidemiology of these uncommon cancers, and address their clinical behavior, and current diagnostic and therapeutic options... - Evolution of the diffuse neuroendocrine system--clear cells and cloudy originsIrvin M Modlin
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, CT 06520, USA
Neuroendocrinology 84:69-82. 2006..Their key role in the regulation of gastrointestinal function is, however, indubitable... - The epidemiology of gastroenteropancreatic neuroendocrine tumorsBen Lawrence
Gastrointestinal Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, 310 Cedar Street, PO Box 208602, New Haven, CT 06520 8062, USA
Endocrinol Metab Clin North Am 40:1-18, vii. 2011..Overall, GEP-NET survival has improved over the past 3 decades, although the outcome for poorly differentiated tumors remains dismal... - Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactantsMark Kidd
1Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Am J Physiol Gastrointest Liver Physiol 295:G260-72. 2008..Luminal EC cell regulation is likely to be as important as G cell regulation in gastric acid secretion; development of agents to target EC cell function is therefore a critical therapeutic goal... - Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and managementIrvin M Modlin
School of Medicine, Yale University, New Haven, Conn, USA
Med J Aust 193:46-52. 2010..The overarching requirement for best management of patients with NETs is to ensure that they have ready access to experienced multidisciplinary clinician groups located within centres of appropriate subspecialty expertise... - GeneChip, geNorm, and gastrointestinal tumors: novel reference genes for real-time PCRMark Kidd
Gastrointestinal Research Group, Yale University School of Medicine, New Haven, Connecticut, USA
Physiol Genomics 30:363-70. 2007.... - Siegfried oberndorfer and the evolution of carcinoid diseaseIrvin M Modlin
Gastric Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, New Haven, CT 06520 8062, USA
Arch Surg 142:187-97. 2007..This exploration of his life and times seeks to give Oberndorfer his well-deserved place in the pantheon of pathology and memorialize his unique observations that led to the discovery of the carcinoid tumor... - Neuroendocrine tumor epidemiology: contrasting Norway and North AmericaOyvind Hauso
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
Cancer 113:2655-64. 2008..Norway also holds a robust and detailed cancer registry: the Norwegian Registry of Cancer (NRC)... - The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasiaMark Kidd
Department of Surgery, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208062, New Haven, Connecticut 06520-8062, USA
Ann Surg Oncol 13:253-62. 2006..The ability to determine the malignant potential of these tumors and their propensity to metastasize provides a biological rationale for the management of carcinoids and may have prognostic utility... - The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumorsBen Lawrence
Gastrointestinal Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, 310 Cedar Street, PO Box 208602, New Haven, CT 06520 8062, USA
Endocrinol Metab Clin North Am 40:111-34, viii. 2011..Clinicians aware of the physiologic role of chromogranin A and its secretion in a variety of non-NET-related pathologic conditions can use this protein as a moderately effective tumor biomarker in the management of GEP-NETs... - A clinical perspective on gastric neuroendocrine neoplasiaBen Lawrence
Yale University School of Medicine, New Haven, CT 06520, USA
Curr Gastroenterol Rep 13:101-9. 2011..Elucidation of the precise biology of a gastric NET is critical to diagnosis and delineation of a type-specific management strategy... - Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptorsMark Kidd
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Cancer 112:1404-14. 2008.... - A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progressIrvin M Modlin
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Am J Gastroenterol 102:1464-73. 2007..We examined patterns, incidence, prognosis, and outcomes of these tumors over a 30-yr period... - Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycinMark Kidd
Department of Surgery, Yale University School of Medicine, TMP202, 333 Cedar Street, New Haven, Connecticut 06520, USA
J Mol Endocrinol 38:181-92. 2007.... - Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor diseaseMark Kidd
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520-8062, USA
Ann Surg 243:273-80. 2006..The use of this sensitive strategy to assess NETs and apparently normal LNs and liver may be of future utility in defining therapeutic strategy... - Gastrointestinal carcinoids: the evolution of diagnostic strategiesIrvin M Modlin
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
J Clin Gastroenterol 40:572-82. 2006.... - Therapeutic options for gastrointestinal carcinoidsIrvin M Modlin
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Clin Gastroenterol Hepatol 4:526-47. 2006..The keystone of current therapy remains the long-acting somatostatin analogues that alleviate symptomatology and substantially improve quality of life with minimal adverse effects... - Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategyKarim M Eltawil
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520 8062, USA
J Clin Gastroenterol 44:687-95. 2010..5% of all NETs, and little is known about their biological behavior. We sought to provide an overview of the current state of knowledge about GB-NETs and provide a recommendation for management... - Biology and management of gastric carcinoid tumours: a reviewIrvin M Modlin
Gastrointestinal Surgical Pathobiology Research Group, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Eur J Surg 168:669-83. 2002..Gastric carcinoids, however, can be managed initially by endoscopic excision of accessible tumours, followed by regular endoscopic surveillance... - From the lumen to the laparoscopeIrvin M Modlin
Gastrointestinal Surgical Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, New Haven, Conn 06520, USA
Arch Surg 139:1110-26. 2004.... - The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasmsSimon Schimmack
Department of Gastroenterological Surgery, Yale University School of Medicine, New Haven, CT, USA
Cancer 118:2763-75. 2012..Given the role of internexin alpha (INA) in neuronal development, the authors assessed its function in neuroendocrine cell systems and the clinical implications of its expression as a GEP-NEN biomarker... - Delineation of the chemomechanosensory regulation of gastrin secretion using pure rodent G cellsMark Kidd
Gastrointestinal Pathobiology Research Group, Department of Gastroenterology, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Gastroenterology 137:231-41, 241.e1-10. 2009..Gastrin is a key regulator of gastric acid secretion. We aimed to isolate pure G cells to identify the mechanistic basis of luminal- and strain-mediated regulation... - The molecular genetics of gastroenteropancreatic neuroendocrine tumorsMichelle N Zikusoka
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062, USA
Cancer 104:2292-309. 2005..On the basis of the evolution of genetic information, enteric neuroendocrine lesions (carcinoids) and PETs may need to be classified as two distinct entities rather than grouped together as the single entity "GEP-NETs.".. - KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor modelZakiya Luna Siddique
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine New Haven, New Haven, CT 06520 8062, USA
Neuroendocrinology 89:458-70. 2009.... - Bronchopulmonary neuroendocrine tumorsBjorn I Gustafsson
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520 8062, USA
Cancer 113:5-21. 2008..This review provides a broad overview on BP-NETs and focuses on the evolution of the disease, general features, and current diagnostic and therapeutic options... - Siegfried Oberndorfer: origins and perspectives of carcinoid tumorsIrvin M Modlin
Gastric Pathobiology Research Group, Department of Surgery, Yale University School of Medinice, New Haven, CT 06520-8062, USA
Hum Pathol 35:1440-51. 2004..It also serves to memorialize the extraordinary accomplishments of Oberndorfer, whose vision exceeded his times... - A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?Irvin M Modlin
Gastrointestinal Surgical Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Am J Gastroenterol 99:23-32. 2004..We sought to examine if there has been an increase in gastric carcinoid incidence time correlative with these parameters... - From Leningrad to London: the saga of Kulchitsky and the legacy of the enterochromaffin cellIgnat Drozdov
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, Conn 06520 8062, USA
Neuroendocrinology 89:1-12. 2009.... - A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survivalIrvin M Modlin
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, CN 06520 8062, USA
Neuroendocrinology 92:143-57. 2010..The development of a mathematically validated nomogram provides a platform for objective assessment of SI NET disease, a finite basis for precise prognostication and a tool to guide management strategy... - Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasiaBen Lawrence
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, CT 208602, USA
BMC Res Notes 5:318. 2012..We hypothesized that detection of CgA mRNA transcripts would be a more sensitive method of detecting these metastases... - Neuroendocrine tumors of the diffuse neuroendocrine systemBjorn I Gustafsson
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Curr Opin Oncol 20:1-12. 2008..25% of all malignancies; their incidence is increasing by approximately 6% per year. The present review provides an overview on neuroendocrine tumors and focuses on general features and current diagnostic and therapeutic options... - Carcinoid tumors and fibrosis: an association with no explanationIrvin M Modlin
Gastric Pathobiology Research Group, Yale University School of Medicine, New Haven, Connecticut 06520-8062, USA
Am J Gastroenterol 99:2466-78. 2004..In addition, we have provided more current mechanistic information in regard to the biological basis of fibrosis associated with small bowel carcinoid tumors... - Gastroesophageal reflux disease: then and nowIrvin M Modlin
Department of Gastroenterological Surgery, Yale University School of Medicine, New Haven, CT 06520 8062, USA
J Clin Gastroenterol 38:390-402. 2004..In this respect, Barrett's esophagus still presents a major biologic and management conundrum for the physicians and scientists alike... - Chromogranin A--biological function and clinical utility in neuro endocrine tumor diseaseIrvin M Modlin
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, CT, USA
Ann Surg Oncol 17:2427-43. 2010..We review here the utility of CgA measurement in NETs and describe its biological role and the clinical value of its measurement... - GERD 2004: issues from the past and a consensus for the futureIrvin Modlin
Department of Surgery, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06520 8062, USA
Best Pract Res Clin Gastroenterol 18:55-66. 2004..A future consensus thus requires the identification of the appropriate tools to detect Barrett's early, identify the specific molecular markers associated with neoplastic transformation and establish a definitive therapeutic algorithm... - Nikolai Konstantinovich Kulchitsky (1856-1925)Ignat Drozdov
Yale University School of Medicine, USA
J Med Biogr 17:47-54. 2009..Kulchitsky's mysterious demise in a bizarre lift-shaft accident at UCL on his 69th birthday tragically terminated a life of service to science... - Friedrich Feyrter: a precise intellect in a diffuse systemManish C Champaneria
Department of Gastroenterological Surgery, Yale University School of Medicine, New Haven, CT 06520-8062, USA
Neuroendocrinology 83:394-404. 2006..We describe the life and times of this gifted scientist, teacher, and pathologist, often referred to as the 'Father of Neuroendocrinology'... - The functional characterization of normal and neoplastic human enterochromaffin cellsIrvin M Modlin
Department of Surgery, TMP202, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, USA
J Clin Endocrinol Metab 91:2340-8. 2006.... - Primary carcinoid tumor of the parotid gland: A case report and review of the literatureIrvin M Modlin
Gastric Pathobiology Research Group, Yale University School of Medicine, New Haven, Conn 06520 8062, USA
Ear Nose Throat J 85:533-9. 2006..In particular, it is important to differentiate them from metastatic tumors from other sites... - Evolution of one-handed piano compositionsIgnat Drozdov
Gastrointestinal Pathobiology Research Group, Yale University School of Medicine, New Haven, CT 06520 8062, USA
J Hand Surg Am 33:780-6. 2008.... - Current status of gastrointestinal carcinoidsIrvin M Modlin
Gastric Pathobiology Research Group, GI Surgical Division, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Gastroenterology 128:1717-51. 2005..Overall 5-year survival for carcinoids of the appendix is 98%, gastric (types I/II) is 81%, rectum is 87%, small intestinal is 60%, colonic carcinoids is 62%, and gastric type III/IV is 33%... - Carcinoid tumors of the stomachIrvin M Modlin
Gastrointestinal Surgical Pathobiology Research Group, Yale University School of Medicine, New Haven, CT 06520 8062, USA
Surg Oncol 12:153-72. 2003..In addition, the clinical rationale of current diagnostic and therapeutic strategies will be examined, providing a logical basis for the formulation of appropriate management strategies for patient care... - GERD 2003: issues from the past and a consensus for the futureIrvin Modlin
Gastric Pathology Research Group, Department of Surgery, Yale University, School of Medicine, New Haven, CT 06520-8062, USA
Drugs Today (Barc) 40:3-8. 2004.... - Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular CarcinomaKarim M Eltawil
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
World J Surg Oncol 8:43. 2010..The purpose of this study was to compare the impact of the type of resection (anatomic versus non-anatomic) on early intra-hepatic HCC recurrence in patients with solitary HCC and preserved liver function... - Small intestinal neuroendocrine cell pathobiology: 'carcinoid' tumorsMark Kidd
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Curr Opin Oncol 23:45-52. 2011..Despite these issues, approximately 350 studies were published in the last year... - An analysis of rare carcinoid tumors: clarifying these clinical conundrumsIrvin M Modlin
Gastric Pathobiology Research Group, Yale University School of Medicine, 333 Cedar Street, P O Box 208062, New Haven, CT 06520 8062, USA
World J Surg 29:92-101. 2005..Familiarity with such unusual sites of origin will facilitate appropriate recognition and characterization of such tumors, allowing for timely intervention... - Gastric stem cells: an updateIrvin M Modlin
Gastrointestinal Surgical Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, New Haven, CT 06520-8062, USA
Keio J Med 52:134-7. 2003..Ultimately, the identification of these pathways will play an important role in identifying new molecular targets for the treatment of gastric disease... - Surgical treatment of achalasia: current status and controversiesFarshad Abir
Department of Surgery, Yale University School of Medicine, New Haven, Conn. 06520-8062, USA
Dig Surg 21:165-76. 2004.... - Multiple gastrointestinal stromal tumors and synchronous ileal carcinoidsMichele Buragas
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA
Nat Clin Pract Oncol 2:166-70; quiz 1 p following 170. 2005..DIAGNOSIS: Multiple gastrointestinal stromal tumors occurring concomitantly with ileal carcinoids. MANAGEMENT: Gastric-wedge resection and segmental resection... - Historical perspectives on the treatment of gastroesophageal reflux diseaseIrvin M Modlin
Yale University School of Medicine, Department of Surgery, TMP 202, 333 Cedar Street, New Haven, CT 06520, USA
Gastrointest Endosc Clin N Am 13:19-55, vii-viii. 2003..Similarly, a specific pharmacotherapeutic probe targeting the lower esophageal sphincter, while long fantasized, remains to be identified... - A 5-decade analysis of 13,715 carcinoid tumorsIrvin M Modlin
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520 8062, USA
Cancer 97:934-59. 2003.... - Gastric and duodenal mucosal protein fractional synthesis and growth factor expression in patients with H. pylori-associated gastritis before and after eradication of the organismTrevor A Winter
Gastrointestinal Clinic, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town 7925, South Africa
Dig Dis Sci 49:925-30. 2004..Eradication of HP results in reduction of gastric, but not duodenal, MPFS and has no effect on the growth factors measured. Increased MPFS associated with HP gastritis may relate to the potential for neoplastic transformation... - Traces of human migrations in Helicobacter pylori populationsDaniel Falush
Department of Molecular Biology, , 10117 Berlin, Germany
Science 299:1582-5. 2003..Subsequent spread can be attributed to human migratory fluxes such as the prehistoric colonization of Polynesia and the Americas, the neolithic introduction of farming to Europe, the Bantu expansion within Africa, and the slave trade... - Investigation of the biological relevance of Helicobacter pylori cagE locus diversity, presence of CagA tyrosine phosphorylation motifs and vacuolating cytotoxin genotype on IL-8 induction in gastric epithelial cellsRobert J Owen
Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK
FEMS Immunol Med Microbiol 36:135-40. 2003.... - The relationship of a Helicobacter heilmannii infection to the mucosal changes in abattoir and laboratory pig stomachAnwar S Mall
Department of Surgery, Faculty of Health Sciences, University of Cape Town, Observatory 7925, Cape Town, South Africa
Surg Today 34:943-9. 2004..003), the JSM group vs sham-operated pigs (P < 0.011), and JSM vs BDL pigs (P < 0.0005), but there appeared to be no association between the infectivity with Hh and mucin degradation... - Multiple gastric carcinoidsIrvin M Modlin
J Am Coll Surg 198:174. 2004 - Investigation of HLA-DPA1 genotypes as predictors of inflammatory bowel disease in the German, South African, and South Korean populationsAnnette Lantermann
Department of General Internal Medicine, Christian Albrechts University, Schittenhelmstrasse 12, 24105 Kiel, Germany
Int J Colorectal Dis 17:238-44. 2002..The HLA-DP genes play an important role in antigen presentation and are located within the chromosome 6p linkage region...